Efficacy and Safety of Topical Brepocitinib for the Treatment of Mild-to-moderate Atopic Dermatitis: a Phase IIb, Randomized, Double-Blind, Vehicle-Controlled, Dose-Ranging and Parallel-Group Study
British Journal of Dermatology（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要